1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Classification of autoantibodies in this cohort into group 1 (intracellular antigens) versus group 2 (extracellular antigens) autoimmune encephalitis
Group 1 AntibodiesGroup 2 Antibodies
Anti-CV2Anti-AMPAr
Anti-GADAnti-CASPR2
Anti-HuAnti-DPPX
Anti-Ma2/TaAnti-GABA A
Anti-YoAnti-GABA B
Anti-GFAP
Anti-GQ1b
Anti-LGI1
Anti-NMDA
Anti-PD1
Anti-VGCC
Anti-VGKC
  • Note:—AMPAr indicates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor.